首页 | 本学科首页   官方微博 | 高级检索  
检索        

多药耐药基因多态性与儿童急性淋巴细胞白血病长期生存的相关性
引用本文:杜智卓,凌婧,吕慧,胡绍燕,柴忆欢.多药耐药基因多态性与儿童急性淋巴细胞白血病长期生存的相关性[J].白血病.淋巴瘤,2016,25(11):655-658.
作者姓名:杜智卓  凌婧  吕慧  胡绍燕  柴忆欢
作者单位:215000,苏州大学附属儿童医院血液科;215000,苏州大学附属儿童医院血液科;215000,苏州大学附属儿童医院血液科;215000,苏州大学附属儿童医院血液科;215000,苏州大学附属儿童医院血液科
基金项目:江苏省科技计划(BK2014285)Fund program:Science and Technology Foundation of Jiangsu Province (BK2014285)
摘    要:目的:探讨多药耐药基因MDR1基因多态性在儿童急性淋巴细胞白血病(ALL)中的发生情况,及其与患儿长期生存的相关性。方法采用多重单碱基延伸单核苷酸多态性基因分型技术检测176例ALL患儿MDR1 C3435T、C1236T、G2677T/A位点的基因型分布特点,分析其与患儿长期(5年)生存的相关性。结果MDR1 C3435T中C/C、C/T、T/T基因型分别有67、94、15例;MDR1 C1236T中C/C、C/T、T/T基因型分别有23、82、71例;G2677T/A中G/T、T/T、T/A、G/G、G/A、A/A基因型分别有66、17、28、37、24、4例。本组176例患儿总体生存率为77.3%(136/176)。MDR1 C3435T中C/C、C/T、T/T基因型患儿的5年无事件生存(EFS)率分别为79.57%、83.33%、33.33%,其中携带T/T基因型患儿的5年EFS率低于携带C/C和C/T基因型的患儿(χ2=15.301,P=0.002)。 MDR1 C1236T中C/C、C/T、T/T基因型患儿的5年EFS分别为52.00%、81.71%、71.93%,其中携带C/C基因型患儿的5年EFS率低于携带C/T和T/T基因型的患儿(χ2=17.800,P=0.001)。结论 MDR1基因多态性与儿童ALL的EFS相关,携带MDR1 C3435T中T/T、MDR1 C1236T中C/C基因型的患儿长期生存率较低。

关 键 词:白血病  淋巴细胞  急性  多药耐药基因  基因多态性  无事件生存

The relationship between MDR1 gene polymorphism and long-time survival in children with acute lymphoblastic leukemia
Du Zhizhuo,Ling Jing,Lyu Hui,Hu Shaoyan,Chai Yihuan.The relationship between MDR1 gene polymorphism and long-time survival in children with acute lymphoblastic leukemia[J].Journal of Leukemia & Lymphoma,2016,25(11):655-658.
Authors:Du Zhizhuo  Ling Jing  Lyu Hui  Hu Shaoyan  Chai Yihuan
Abstract:Objective To study the frequency distribution patterns of gene polymorphism of multidrug resistance gene MDR1 in children with acute lymphoblastic leukemia (ALL), and their relationship with long-time survival. Methods A case-control study was carried out to compare the distribution of genotype and genetic frequency of MDR1 C3435T, C1236T and G2677T/A in 176 children with ALL by single nucleotide polymorphisms-shot (SNP-shot) method. Results MDR1 C3435T C/C, C/T, T/T took 67, 94 and 15 cases respectively; MDR1 C1236T C/C, C/T, T/T took 23, 82 and 71 cases respectively; G2677T/A G/T, T/T, T/A, G/G, G/A and A/A took 66, 17, 28, 37, 24 and 4 cases respectively. The overall survival rate of 176 children in this group was 77.3%(136/176). The 5-year event-free survival (EFS) rates in children with MDR1 C3435T C/C, C/T and T/T were 79.57 %, 83.33 % and 33.33 % respectively. The EFS rate in children with T/T genotype was lower than those in C/C and C/T genotypes (χ2=15.301, P=0.002). The 5-year EFS rates in patients with MDR1 C1236T C/C, C/T and T/T were 52 %, 81.71 % and 71.93 % respectively. The EFS rate in patients with C/C genotype was lower than those in C/T and T/T genotypes (χ2=17.800, P=0.001). Conclusions The gene polymorphism of MDR1 is related to the EFS of children with ALL. The survival rates in children with MDR1 C1236T C/C and C3435T T/T genotypes are lower than those in other genotypes.
Keywords:Leukemia  lymphocyte  acute  Multidrug resistance gene  Gene polymorphism  Event-free survival
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号